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Supply of methionine and arginine alters
phosphorylation of mechanistic target of
rapamycin (mTOR), circadian clock proteins,
and α-s1-casein abundance in bovine mammary
epithelial cells†
Liangyu Hu,a,b Yifei Chen,a Ismael M. Cortes,c Danielle N. Coleman,b Hongyu Dai,b,d
Yusheng Liang,b Claudia Parys,e Carlos Fernandez,f Mengzhi Wang*a and
Juan J. Loor *b
Methionine (Met) and arginine (Arg) regulate casein protein abundance through alterations in activity of
the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. A potential role for the cir-
cadian clock network on the regulation of protein synthesis, partly via activity of mTORC1, has been high-
lighted in non-ruminants. The main objective of the study was to determine in ruminant mammary cells
alterations in mRNA, protein abundance and phosphorylation status of mTORC1-related upstream targets,
circadian clock proteins, and protein kinase AMP-activated catalytic subunit alpha (AMPK) in relation to α-
s1-casein protein (CSN1S1) abundance in response to greater supply of Met and Arg alone or in combi-
nation. Primary bovine mammary epithelial cells (BMEC) were incubated for 12 h in a 2 × 2 arrangement
of treatments with control media (ideal profile of amino acids, IPAA), or media supplemented with
increased Met (incMet), Arg (incArg), or both (incMet + incArg). Data were analyzed testing the main
effects of Met and Arg and their interaction. Among 7 amino acid (AA) transporters known to be mTORC1
targets, increasing supply of Arg downregulated SLC1A5, SLC3A2, SLC7A1, and SLC7A5, while increasing
supply of Met upregulated SLC7A1. mRNA abundance of the cytosolic Arg sensor (CASTOR1) was lower
when supply of Arg and Met alone increased. p-TSC2 (TSC complex subunit 2) was greater when the Arg
supply was increased, while the phosphoralation ratio of p-AKT (AKT serine/threonine kinase 1):total (t)
AKT and p-AMPK:tAMPK were lower. In spite of this, the ratio of p-mTOR:tmTOR nearly doubled with
incArg but such response did not prevent a decrease in CSN1S1 abundance. The abundance of period cir-
cadian regulator 1 (PER1) protein nearly doubled with all treatments, but only incMet + incArg led to
greater clock circadian regulator (CLOCK) protein abundance. Overall, data suggest that a greater supply
of Met and Arg could influence CSN1S1 synthesis of BMEC through changes in the mTORC1, circadian
clock, and AMPK pathways. Identifying mechanistic relationships between intracellular energy, total AA
supply, and these pathways in the context of milk protein synthesis in ruminants merits further research.
Introduction
Amino acids (AA) can be used by the mammary gland as sub-
strates to synthesize milk protein1 and as signaling factors to
regulate casein protein gene transcription and translation
through pathways2–4 such as the mechanistic target of rapamy-
cin complex 1 (mTORC1). Methionine (Met) is identified fre-
quently in dairy cows as the most-limiting AA for milk and
milk protein synthesis,5,6 especially on highly corn-based
diets.7 Arginine (Arg) belongs to the conditionally-essential
amino acids (EAA)8 that indirectly could affect milk protein
synthesis.9
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Providing a well-balanced supply of EAA can serve as an
opportunity to increase the efficiency of metabolizable protein
(MP) utilization for milk protein yield.10 Rulquin et al. (2007)11
proposed an ideal profile for intestinally-absorbed EAA in the
form of percentage of MP in which a 7.3% Lys to 2.5% Met was
deemed optimal. This relationship was subsequently tested by
Haque et al. (2012)10 where balancing the EAA profiles was inde-
pendent of MP supply levels. Nan et al. (2014)12 working with
mammary cells provided data suggesting that a ratio of
Lys : Met at about 2.9 : 1 was optimum for enhancing casein
concentration in vitro, partly via alterations in mRNA and
protein abundance of mTORC1 targets. In the case of Arg, pub-
lished recommendations range from 3.1%13 to 4.8%14 of MP,
and Haque et al. (2013)15 subsequently concluded that com-
pared with highest levels proposed a supply of 3.5% Arg of MP
(Lys : Arg at 2 : 1) was not limiting for milk protein synthesis.
Recent in vitro studies reported a positive effect of greater
Arg supply (Lys : Arg at 1 : 1) on mRNA and protein abundance
of various components of the milk protein synthesis
network,16 but a negative impact of supplying Met beyond the
3 : 1 ratio of Lys : Met.17 Although most published studies have
focused on the optimal supply of Met and Arg with respect to
the role of mTORC1 downstream factors on milk protein syn-
thesis, recent research has identified important roles of factors
upstream of mTORC1,18,19 AA transporters20 and AA
sensors21,22 in the overall regulation of protein synthesis.
Thus, detailed mechanisms encompassing not only mTORC1
in response to changes in AA supply merit further research.
The circadian clock, a mammalian internal timing system
present in all organs,23 orchestrates temporal physiology to
optimize the timing of metabolic processes.24–26 mTORC1 is
capable of coupling environmental inputs, including AA avail-
ability, to the circadian clock and its signaling network. Data
from a recent review of the non-ruminant literature under-
scored a reciprocal interplay between circadian clock and
mTORC1 signaling,27 with a key premise being that mTORC1
activity is regulated by the circadian clock. In turn, the rhyth-
micity of mTORC1 and its downstream signaling components
impact autonomous properties as well as core clock proteins
both in suprachiasmatic nucleus (SCN) and some peripheral
tissues (e.g. liver).28 Although not known, bidirectional regu-
lation between circadian clock and mTORC1 may also be part
of the mechanisms controlling milk protein synthesis in
mammary gland. Thus, as underscored by the recognition that
there are annual rhythms in milk yield and milk com-
ponents,29 adding this dimension to research of mechanisms
controlling milk protein synthesis is needed for an integrated
understanding of mammary cell physiology.
In this study, we hypothesized that a greater supply of Met
or Arg based on an ideal AA profile which has been used in
cell culture studies from our laboratory17,30,31 stimulates
casein protein abundance in bovine mammary epithelial cells
(BMEC). We used mRNA and protein abundance analyses to
explore the potential molecular mechanisms involved in the
coordination of upstream components of mTORC1 signaling
and the circadian clock network.
Materials and methods
Cell culture
The cell culture was performed using primary BMEC (kindly
provided by Prof. Mengzhi Wang, Yangzhou University). The
BMEC cells were allowed to grow in cell dishes (BioLite
100 mm, #130182, Thermo Scientific, Rochester, NY) at 37 °C
and 5% CO2 to generate enough biological material, and were
then transferred into 6-well plates (1.2 × 105 cells per well,
#140675, Thermo Scientific, Waltham, MA) with basal media
composed of high-glucose Dulbecco’s modified Eagle’s media
(1, #11995, Gibco, Carlsbad, CA), 10% fetal bovine serum
(#16140, Gibco, Invitrogen, Carlsbad, CA) and 1× penicillin/
streptomycin (#sv30010, HyClone, South Logan, UT). Cells
grew to approximately 90% confluence before imposing treat-
ments as described previously.32
Treatments and experimental design
The BMEC in 6-well plates (about 90% confluence) were
serum-starved overnight and then incubated (n = 5 replicates
per treatment) for 12 h with 4 modified lactogenic media as
follows: media with ideal profile of AA10,15 as the control
(IPAA; Lys : Met 2.9 : 1, Lys : Arg 2 : 1), and treatment media was
supplemented with increased Met (incMet, Lys : Met 2.5 : 1),
Arg (incArg, Lys : Arg 1 : 1), or both (incMet + incArg; Lys : Met
2.5 : 1, Lys : Arg 1 : 1) based on the IPAA.
The modified lactogenic media was prepared according to
Dong et al. (2018).17,33 The 10 EAA (L-isomer, Sigma-Aldrich,
St Louis, MO) were individually added into the custom high-
glucose DMEM (devoid of these 10 EAA, custom made from
Gibco, Carlsbad, CA). Treatment media were prepared by
increasing only Met, Arg or both while keeping the concen-
trations of 7 other EAA (histidine, isoleucine, leucine, phenyl-
alanine, threonine, tryptophan, valine) the same across all
media (Table 1).
RNA extraction and quantitative RT-PCR analysis
After 12 h of incubations with treatments, BMEC were scraped
using a cell lifter in 1 mL of QIAzol reagent (#79306, Qiagen,
Valencia, CA) and total RNA was obtained using the RNeasy
Mini kits (#74104, Qiagen, Valencia, CA). The RNA concen-
tration and integrity were determined by ND-1000 spectro-
photometer (Nano-Drop Technologies, Wilmington, DE) and
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA). Samples for subsequent analysis had an RNA Integrity
Number (RIN) ≥8.0, and 100 ng of RNA was used for cDNA
synthesis.
Quantitative real-time polymerase chain reaction (qRT-PCR)
was performed as described previously. The list of target genes
is reported in ESI Table 1.† Briefly, 4 μL diluted cDNA was
combined with 6 μL of a mixture composed of 5 μL 1× SYBR
Green Master Mix (Quanta, Gaithersburg, MD), 0.4 μL each of
10 μM forward and reverse primers, and 0.2 μL RNase free
water. Reaction mixtures were preheated at 95 °C for 5 min,
followed by 40 cycles of melting at 95 °C for 15 s, and anneal-
ing at 60 °C for 30 s. The standard curve method and
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QuantStudio™ 7 Flex Real-Time PCR Software (Applied
Biosystems, CA) were used for data analysis. The internal con-
trols used for normalization of target gene abundance were
glyceraldehyde-3-phosphate dehydrogenase (GADPH), ubiqui-
tously expressed prefoldin like chaperone (UXT ), and riboso-
mal protein S9 (RPS9). The expression of the internal control
genes was not affected by treatment (P > 0.10). Normalization
of the target gene abundance was performed by dividing their
relative abundance by the geometric mean of the three internal
control genes. Primers (ESI Table 1†) were designed and veri-
fied based on established protocols in our laboratory.34
qRT-PCR performance was reported in ESI Table 2.†
Western blotting
Complete details of these protocols are reported in our pre-
vious publications. Briefly, the BMEC were washed three times
with phosphate-buffered saline, and total protein collected
using ice-cold M-PER mammalian protein extraction reagent
(#78501, Thermo Scientific, Waltham, MA) containing 1% halt
protease and phosphatase inhibitor cocktail (#78440, Thermo
Scientific). Lysates were centrifuged at 14 000g for 10 min at
4 °C, and then the supernatants harvested for measuring and
normalizing protein concentration with the BCA protein assay
kit (#23227, Thermo Scientific). Proteins (20 µL of total
protein) and 4× Laemmli sample buffer (#161-0747, Bio-Rad,
Hercules, CA) were mixed at a ratio of 3 : 1 (wt : vol) and
denatured at 95 °C for 10 min. Samples were subjected to 10%
SDS/PAGE and then transferred to a PVDF membrane
(#1620261, Bio-Rad) by using Trans-Blot SD Semi-Dry
Electrophoretic Transfer Cell (#170-3940, Bio-Rad) for 25 min,
and PVDF membranes were incubated with primary antibody
(listed in ESI Table 3†) overnight at 4 °C after blocking for 2 h
with 5% skim milk (#1706404XTU, Bio-Rad) for total proteins
or 5% bovine serum albumin (#A7960, sigma, St Louis, MO)
for phosphorylated proteins and casein at room temperature.
The PVDF membranes were then washed 6 times (5 min per
time) and incubated with secondary antibody for 1.5 h at room
temperature before washing again. The visualization of PVDF
membranes was performed using the ChemiDoc MP System
(Bio-Rad) with Clarity Western ECL Substrate (#170-5060, Bio-
Rad) reagent. Band intensities were quantified using Image
Lab software (version 3.0, Bio-Rad), and phosphorylation state
was calculated as the intensity ratio of phosphorylated protein
to total protein (arbitrary units). The intensity of GAPDH was
used to normalize target protein abundance.
Statistical analysis
All data were analyzed as a 2 × 2 factorial arrangement of treat-
ments using the MIXED procedure of SAS 9.4 (SAS Institute
Inc., Cary, NC). The main factors were Met and Arg, with each
containing 2 levels: “yes” the AA was greater or “no” it was the
same as IPAA. The model tested the effects of Met, Arg and the
interaction between them. Least square means and standard
errors were determined using the LSMEANS statement and
means were compared using Tukey’s when a significant inter-
action between Met and Arg was observed. Variables were
assessed for normality of distribution using the Shapiro–Wilk
test. mRNA abundance data were log2-scale transformed to fit
normal distribution of residuals. The tables contain the log2
back-transformed means that resulted from analysis.
Significance was declared at P ≤ 0.05 and tendencies as P ≤ 0.10.
Results
mRNA abundance
AA transporters. No significant interaction between
increased supply of Met and Arg was observed for all AA trans-
porters (P > 0.10). Abundance of solute carrier family
7 member 1 (SLC7A1, functions described in ESI Table 4†) was
greater with increased Met supplementation (P = 0.003;
Table 2) and lower with Arg supplementation (P = 0.011).
There was also an overall effect of Arg on SLC7A5, SLC3A2, and
SLC1A5 (P < 0.0001) where mRNA abundance decreased when
Arg supply was increased. The mRNA abundance of SLC1A1,
SLC38A2, and SLC38A9 was not significantly different (P >
0.05) with AA treatment.
AA sensors and upstream factors in the mTOR pathway. A
tendency for a Met × Arg interaction was observed for WD
repeat domain 24 (WDR24, P = 0.083; Table 2) where treatment
with incMet and incArg alone or in combination decreased
mRNA abundance compared with IPAA (P < 0.05). Additionally,
compared with incArg, culture with incMet and incMet +
incArg led to lower abundance of WDR24 (P < 0.05). No signifi-
cant Met × Arg interaction was observed for the other AA
Table 1 Amino acid (AA) compositiona of the ideal AA profile (IPAA;
Lys : Met 2.9 : 1, Lys : Arg 2 : 1) and treatments supplemented with
increased Arg (incArg), Met (incMet), or both (incMet + incArg)
Amino acid
Treatments
IPAAb incArg incMet incMet + incArg
Concentration (μg mL−1)
L-Lysine 175 175 175 175
L-Methionine 60 60 70 70
L-Arginine 84 175 84 175
L-Histidine 74 74 74 74
L-Isoleucine 121 121 121 121
L-Leucine 206 206 206 206
L-Phenylalanine 93 93 93 93
L-Threonine 97 97 97 97
L-Tryptophan 16 16 16 16
L-Valine 142 142 142 142
Ratio
Lys : Met 2.9 : 1 2.9 : 1 2.5 : 1 2.5 : 1
Lys : Arg 2 : 1 1 : 1 2 : 1 1 : 1
a The AA were individually added into the custom high-glucose
Dulbecco’s modified Eagle’s media (DMEM) devoid of these 10 EAA.
Concentrations of other AA in the custom high-glucose DMEM are
glycine = 30 μg mL−1, L-cystine = 63 μg mL−1, L-glutamine = 584 μg
mL−1, L-serine = 42 μg mL−1, and L-tyrosine = 104 μg mL−1. b IPAA =
ideal profile of AA, Lys : Met 2.9 : 1, Lys : Arg 2 : 1; incArg = increased
supply of Arg, Lys : Met 2.9 : 1, Lys : Arg 1 : 1; incMet = increased supply
of Met, Lys : Met 2.5 : 1, Lys : Arg 2 : 1; incMet + incArg = increased
supply both of Met and Arg, Lys : Met 2.5 : 1, Lys : Arg 1 : 1.
Concentrations and ratios of other 7 AA were the same in all groups.
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sensors and upstream factors in the mTOR pathway that were
evaluated. Abundance of cytosolic arginine sensor for
mTORC1 subunit 1 (CASTOR1) was lower with greater supply
of Met (P = 0.002) and Arg (P = 0.05; Table 2). Incubation with
increased supply of Arg led to lower mRNA abundance of
meiosis regulator for oocyte development (MIOS, P = 0.014)
and greater abundance of DEP domain containing 5 (DEPDC5,
P = 0.007). For members of the Rag GTPases, increased supply
of Met resulted in lower mRNA abundance of Ras related GTP
binding A (RRAGA, P = 0.011). Abundance of taste 1 receptor
member 3 (TAS1R3) and phosphatidylinositol 3-kinase catalytic
subunit type 3 (PIK3C3) did not differ statistically due to Arg,
Met or their interaction (P > 0.05).
AMPK–SIRT1 pathway related genes. No significant inter-
action between Met and Arg was observed for the mRNA abun-
dance of genes related to the AMPK–SIRT1 pathway. There was
an overall effect of Arg on sirtuin 1 (SIRT1, P < 0.0001) where
mRNA abundance was decreased when Arg supply was
increased (Table 2). Abundance of nicotinamide phosphoribo-
syltransferase (NAMPT ) was lower in response to both
increased supply of Met (P = 0.046) and Arg (P < 0.0001). No
statistical difference was detected for serine/threonine kinase
11 (STK11) abundance in response to AA treatments (P > 0.05).
Protein abundance and phosphorylation status
Regulators of mTORC1. There were no statistical differences
for the protein abundance of CASTOR1, MIOS, NPR3 like,
GATOR1 complex subunit (NPRL3), RRAGA, or PIK3C3 in
response to Arg, Met or their interaction (P > 0.05; Table 3).
Similarly, protein abundance of the AA sensor TAS1R1 did not
Table 2 Effects of incubating primary bovine mammary cells with the ideal AA profole (IPAA; Lys : Met 2.9 : 1, Lys : Arg 2 : 1), and increased supply of
Arg (incArg), Met (incMet), or both (incMet + incArg) on relative mRNA abundance (log2-scale)




IPAA incArg incMet incMet + incArg SEM Met Arg Met × Arg
Amino acid (AA) transport
SLC1A1 0.92 0.94 0.89 0.92 0.01 0.098 0.108 0.544
SLC1A5 1.17 0.94 1.16 0.92 0.03 0.567 <0.0001 0.829
SLC3A2 1.10 0.89 1.14 0.98 0.04 0.069 <0.0001 0.446
SLC7A1 0.65 0.57 0.74 0.66 0.03 0.003 0.011 0.789
SLC7A5 1.25 1.00 1.25 0.99 0.04 0.843 <0.0001 0.913
SLC38A2 1.01 1.03 1.06 1.09 0.04 0.140 0.579 0.820
SLC38A9 1.02 0.95 0.94 0.95 0.03 0.202 0.270 0.178
AA sensors and intracellular signaling
CASTOR1 1.24 1.19 1.04 0.77 0.10 0.002 0.051 0.120
MIOS 1.26 1.00 1.08 1.01 0.07 0.180 0.014 0.150
DEPDC5 1.06 1.13 1.05 1.13 0.03 0.876 0.007 0.752
RRAGA 1.19 1.16 1.14 1.14 0.02 0.011 0.281 0.498
WDR24 1.02 0.96 0.90 0.90 0.02 <0.0001 0.068 0.083
TAS1R3 0.44 0.51 0.46 0.47 0.03 0.663 0.186 0.319
PIK3C3 0.99 0.96 0.97 0.98 0.03 0.985 0.741 0.546
AMPK–SIRT1 pathway genes
SIRT1 1.27 1.10 1.24 1.10 0.03 0.644 <0.0001 0.554
NAMPT 1.12 1.03 1.10 0.95 0.02 0.046 <0.0001 0.143
STK11 1.07 1.04 1.08 1.08 0.03 0.397 0.702 0.611
amRNA data were log2-scale transformed to fit normal distribution of residuals, and analyzed least squares means (LSM) and standard errors
(SEM) were log2 back-transformed.
Table 3 Effects of incubating primary bovine mammary cells with the ideal AA profile (IPAA; Lys : Met 2.9 : 1, Lys : Arg 2 : 1), and increased supply of
Arg (incArg), Met (incMet), or both (incMet + incArg) on relative protein abundancea of upstream regulators of mTORC1
Protein
Treatment P-Values
IPAA incArg incMet incMet + incArg SEM Met Arg Met × Arg
CASTOR1 0.14 0.19 0.19 0.19 0.02 0.143 0.204 0.227
MIOS 0.57 0.55 0.50 0.59 0.05 0.776 0.388 0.179
NPRL3 0.61 0.68 0.58 0.66 0.07 0.714 0.283 0.916
RRAGA 0.80 0.85 0.80 0.84 0.06 0.923 0.500 0.930
PIK3C3 0.50 0.43 0.43 0.44 0.08 0.686 0.688 0.584
TAS1R1 0.46 0.49 0.43 0.53 0.05 0.866 0.170 0.511
a The intensity of GAPDH (arbitrary units) was used to normalize target protein abundance (i.e. target protein abundance = total target protein
intensity/GAPDH intensity).
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differ statistically due to AA treatments (P > 0.10).
Representative western blots are reported in ESI Fig. 1†
α-S1-casein and mTORC1 related pathways. An interaction
(P = 0.005; Table 4) between Met and Arg was observed for the
abundance of mTOR; compared with IPAA, incArg and
incMet alone or in combination led to lower protein abun-
dance of mTOR (P < 0.05). An interaction was also observed for
the abundance of p-mTOR (P = 0.04) and p-AMPK (protein
kinase AMP-activated catalytic subunit alpha) (P = 0.006) where
incMet + incArg had lower p-mTOR abundance compared with
incArg (P = 0.04), while incArg led to lower p-AMPK compared
with IPAA (P = 0.002) and incMet (P = 0.04). In spite of this,
there was a Met × Arg interaction for the ratio of p-mTOR:total
(t) mTOR (P = 0.002) which nearly doubled with incArg com-
pared with IPAA (P = 0.02). However, such response did not
prevent a decrease in α-s1-casein protein abundance (CSN1S1,
interaction P = 0.03). There was also a tendency of Met × Arg
for p-TSC2 (TSC complex subunit 2):tTSC2 (P = 0.064); com-
pared with IPAA, treatment with incArg (P = 0.003) and incMet
+ incArg (P = 0.009) led to greater p-TSC2:tTSC2. Additionally,
the abundance of p-TSC2 (P = 0.006) was greater with
increased supply of Arg.
An overall effect of Arg on p-AKT (AKT serine/threonine
kinase 1) (P = 0.02), p-AKT:tAKT (P = 0.049), and p-AMPK:
tAMPK (P = 0.007) was observed where abundance was
decreased when Arg supply increased. No statistical difference
(P > 0.05) was detected for total protein abundance of AKT,
AMPK, TSC2, extracellular regulated protein kinase (ERK), as
well as phosphorylation status of ERK. Representative western
blots are reported in ESI Fig. 2.†
Circadian clock proteins. There was a Met × Arg interaction
for period circadian regulator 1 (PER1, P = 0.008; Table 5) and
clock circadian regulator (CLOCK, P < 0.0001) where abun-
dance of PER1 nearly doubled with increased Met and Arg
alone or in combination compared with IPAA (P < 0.05), but
only incMet + incArg led to greater CLOCK abundance than
other treatments (P < 0.01). In addition, increased Met supply
(P = 0.049) and increased Arg supply (P = 0.004) individually
resulted in lower abundance of CLOCK. Abundance of period
circadian regulator 2 (PER2) protein was lower in response to
greater supply of Arg (P = 0.016). However, protein abundance
of aryl hydrocarbon receptor nuclear translocator like (ARNTL,
formerly BMAL1) and cryptochrome circadian regulator 1
(CRY1) did not differ statistically due to Arg, Met or their inter-
action (P > 0.05). Representative western blots are reported in
ESI Fig. 3.†
Discussion
Without supplemental rumen-protected Met, the ratio of
Lys : Met often ranges between 3.6 : 1 and 3.8 : 1 in corn silage-
based diets.6,35 The currently-accepted IPAA ratio to maximize
milk protein content and yield in established lactation is
approximately 2.9 : 1 Lys : Met and is achieved by feeding
rumen-protected Met.10–12,36 Increasing the post-ruminal
supply of Met in dairy cows to levels in IPAA by feeding rumen-
protected supplements has positive effects on production per-
formance,6 milk protein content,37,38 and other physiological
functions such as the immune response.39,40 As for Arg, com-
Table 4 Effects of incubating primary bovine mammary cells with the ideal AA profile (IPAA; Lys : Met 2.9 : 1, Lys : Arg 2 : 1), and increased supply of
Arg (incArg), Met (incMet), or both (incMet + incArg) on relative protein abundance and/or phosphorylation statusa of α-s1-casein and components
of the mTOR, insulin, and energy metabolism pathways
Protein
Treatment P-Value
IPAA incArg incMet incMet + incArg SEM Met Arg Met × Arg
Total
CSN1S1 0.35a 0.20b 0.24ab 0.30ab 0.05 0.916 0.364 0.034
ERK 1.49 1.56 1.51 1.52 0.08 0.824 0.622 0.666
AKT 0.65 0.52 0.54 0.61 0.06 0.850 0.601 0.067
AMPK 0.73 0.54 0.71 0.82 0.11 0.213 0.691 0.170
TSC2 0.75 0.56 0.62 0.66 0.07 0.866 0.280 0.097
mTOR 0.48a 0.28b 0.32b 0.32b 0.03 0.069 0.004 0.005
Phosphorylated
p-ERK 1.44 1.79 1.49 1.62 0.20 0.739 0.209 0.546
p-AKT 0.66 0.45 0.55 0.36 0.08 0.219 0.019 0.898
p-AMPK 0.50a 0.13b 0.37a 0.36ab 0.06 0.392 0.004 0.006
p-TSC2 0.07 0.15 0.11 0.17 0.02 0.193 0.006 0.600
p-mTOR 0.42ab 0.48a 0.42ab 0.29b 0.05 0.039 0.439 0.042
Phosphorylated:total
p-ERK:tERK 0.98 1.14 0.98 1.08 0.12 0.797 0.255 0.788
p-AKT:tAKT 0.99 0.86 1.06 0.53 0.17 0.387 0.049 0.207
p-AMPK:tAMPK 0.71 0.33 0.55 0.43 0.08 0.744 0.007 0.115
p-TSC2:tTSC2 0.08 0.27 0.19 0.25 0.03 0.158 0.001 0.064
p-mTOR:tmTOR 0.72b 1.51a 1.32ab 0.90ab 0.20 0.752 0.236 0.002
a–cMeans within a row with different superscripts differ (Met × Arg, P < 0.05). a The intensity of GAPDH (arbitrary units) was used to normalize
target protein abundance (i.e. target protein abundance = total target protein intensity/GAPDH intensity). The phosphorylation status was calcu-
lated as the intensity ratio of phosphorylated protein to total protein (arbitrary units).
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pared with other EAA, there are inconsistent recommendations
for optimal requirements.15 However, previous work indicated
that a 2 : 1 Lys : Arg would not be detrimental to milk protein
synthesis.13–15
The present study aimed to mimic feeding conditions that
could potentially be achieved in the field in order to modify
the ratio of EAA available to mammary cells to test the effects
of increased supply of Met (Lys : Met = 2.5 : 1) and Arg
(Lys : Arg = 1 : 1) using their profiles in the IPAA as a guide.
Thus, the levels of Met and Arg used in the present study were
in accordance with our previous work.16,17 Within those
in vitro studies, although there was an overall positive effect on
mammary cell metabolism, the negative effects on phosphoryl-
ation of 4E binding protein 1 (EIF4EBP1), eukaryotic elonga-
tion factor 2 (EEF2),16 mTOR,17 and mRNA abundance of
β-casein and AA transporters17 were partly consistent with the
present results. Similarly, despite using EAA profiles similar to
those in IPAA, previous in vivo studies also reported results
contrary to ours, for instance phosphorylation ratio of riboso-
mal protein S6 (RPS6) was lower at a Lys : Met = 2.9 : 141 and
milk protein synthesis or the efficiency of N utilization was not
modified at an Lys : Arg = 2 : 1.15 Thus, it seems plausible that
the decrease in CSN1S1 abundance observed in the present
study in response to 2.5 : 1 Lys : Met and 1 : 1 Lys : Arg
resembles the in vivo response. Clearly, from a practical pro-
duction standpoint, the focus should be in reaching at the very
least the levels of Met and Arg that are in the IPAA. However,
depending on stage of lactation, e.g. early versus late lactation,
additional supply of Met and Arg could benefit health and pro-
duction performance.
AA transport and sensing
The availability of AA is instrumental to the efficiency of milk
protein synthesis,42,43 with Met and Arg being two of the most-
limiting and the most-extracted from blood by bovine
mammary gland. Due to selective barrier function,44 AA
require membrane-spanning AA transporters (AAT) for entry
into and out of cells. The stage of lactation in dairy cows34 and
AA profiles in the MP17 have been suggested to elicit some
direct or indirect control over the transcription of AAT in
mammary cells.
Among 7 AAT known to be mTORC1 targets, the opposite
response in SLC7A1 mRNA abundance (Arg and Lys transpor-
ter) elicited with incMet or incArg suggested a different sensi-
tivity to additional supply of Arg and Met. The fact that
SLC7A1 mRNA abundance was lower with greater Arg supply
agrees with previous studies in ruminants45 and non-rumi-
nants.46 The down-regulation in mRNA abundance of SLC7A5,
SLC3A2, and SLC1A5 in response to greater Arg supply
suggested a negative feedback on the uptake of AA when other
EAA are constant, possibly because cells were trying to deal
with too high concentrations of Met or Arg. We also recently
detected similar responses with increased supply of Met in
MAC-T cells.17
An important consideration to keep in mind is the fact that
SLC3A2 and SLC7A5 counter-transport cationic AA out of
mammary cells, suggesting the possibility that beyond a
certain extracellular concentration the AAT mechanisms might
become saturated. More importantly, because SLC7A5, SLC3A2
and SLC1A5 have a reciprocal regulatory connection with
mTORC147 and are stimulated via mTOR activity when exogen-
ous AA supplementation increases,48 it seems plausible that
greater supply of Met and Arg to BMEC could influence milk
protein synthesis potentially via regulating AA transport
through its effect on transcription of those AAT.
In addition to AAT-mediated regulation on milk protein syn-
thesis,49 AA play a regulatory role by inducing changes in
upstream mTORC1 signaling sensing components.50 Of note,
the cytosolic Arg sensors for mTORC1 (i.e., CASTOR proteins)
link this AA with the mTORC1 pathway.51 In fact, Arg disrupts
the interaction of CASTOR dimers with the GATOR2 complex,
presumably allowing free GATOR2 to inhibit the GATOR1
complex.52 The GATOR2 complex protein WDR24 is particu-
larly important in sensing AA and activating mTORC1.53
Activation of GATOR2 further activates mTORC1 through the
active Rag GTPases54 that aid in localizing mTORC1 to lyso-
somes where the protein Ras homolog, mTORC1 binding
(RHEB) is located55 (Fig. 1).
In the present study, despite the lack of differences at the
protein level, the lower mRNA abundance of CASTOR1 with
increased supply of Arg and Met was consistent with greater
phosphorylation status of mTOR, likely because less CASTOR1
interacting with GATOR2 alleviates their negative regulation on
Table 5 Effects of incubating primary bovine mammary cells with the ideal AA profile (IPAA; Lys : Met 2.9 : 1, Lys : Arg 2 : 1), and increased supply of
Arg (incArg), Met (incMet), or both (incMet + incArg) on relative abundance of circadian clock-related proteinsa
Protein
Treatment P-Values
IPAA incArg incMet incMet + incArg SEM Met Arg Met × Arg
CLOCK 0.15b 0.10c 0.11c 0.22a 0.02 0.001 0.059 <0.0001
ARNTL 0.79 0.74 0.70 0.67 0.12 0.481 0.703 0.922
CRY1 0.37 0.31 0.34 0.37 0.03 0.644 0.636 0.167
PER1 0.27b 0.51a 0.46a 0.40a 0.05 0.037 0.003 0.008
PER2 0.30 0.24 0.34 0.17 0.04 0.820 0.016 0.211
a–cMeans within a row with different superscripts differ (Met × Arg, P < 0.05). a The intensity of GAPDH (arbitrary units) was used to normalize
target protein abundance (i.e. target protein abundance = total target protein intensity/GAPDH intensity).
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mTOR activity.56 Greater supply of Arg was associated with the
dissociation of CASTOR1 from GATOR2, which might explain
the lower abundance of CASTOR1. Because the protein abun-
dance of CASTOR1, MIOS (subunit of GATOR2), and RRAGA
did not differ due to Arg or Met alone or in combination, the
observed differences at the mRNA abundance level are difficult
to explain. However, the differences in p-mTOR:tmTOR and
total CSN1S1 abundance indicate that greater activation of
mTOR alone might be insufficient to enhance CSN1S1 syn-
thesis. Whether the other 3 casein isoforms would respond in
a similar fashion is unknown.
Upstream signaling from mTORC1
In non-ruminants, a large array of factors required for protein
synthesis affects the mTORC1 signaling pathway via interact-
ing with the tuberous sclerosis (TSC1/TSC2) complex57 in
which TSC2 acts as a GTPase-activating protein towards RHEB
to impact mTORC1 activity.58 Our theoretical model (Fig. 1)
mainly focuses on two signaling pathways upstream of
mTORC1 with TSC2 being a key integration point to link regu-
lators that coordinate nutrient signals (AA availability), cellular
energy status, and protein synthesis.
Availability of AA could feed into the core PIK3C3-AKT
pathway that assembles AAT and targets TSC2 functioning
downstream of AKT and upstream of mTORC1.59 Upon acti-
vation of PIK3C3, AKT further activates mTORC1 through
phosphorylating and inactivating TSC2 on Thr14,60,62 or
directly phosphorylates mTORC1.61 The lack of statistically sig-
nificant effect on mRNA and protein abundance of PIK3C3
and the fact that most AAT for Arg and Met measured in the
present study were downregulated with the treatments
suggests that intracellular AA availability might not have been
enough. Other signaling events leading from activation of
PIK3C3 to downstream changes in cell physiology, particularly
the response of intracellular [Ca2+]i or insulin, merit detailed
research.
The lower phosphorylation ratio of p-AKT:tAKT (i.e. less
active AKT) with greater supply of Arg (particularly when com-
bined with greater Met) might partly explain the greater
p-TSC2 in the present study, i.e., less repression of AKT on
TSC2. However, the fact that increased Arg supply also nearly
doubled the p-mTOR:tmTOR ratio seems contradictory. As
Sekulić et al. (2000)61 reported that phosphorylation of mTOR
by AKT had no subsequent influence on downstream targets
(e.g. RPS6K1 and EIF4EBP1), whether the greater p-mTOR:
tmTOR might be the result of other kinases remains to be
determined. The phosphorylation ratio changes in mTOR were
due primarily to a reduction in total mTOR. In that context,
too high concentrations of Met and Arg relative to the ideal AA
profile might explain the decrease in CSN1S1 and total mTOR
protein detected in the present study.
Because the response on p-AMPK:tAMPK ratio due to
incArg was similar to p-AKT:tAKT, we speculate that intracellu-
lar glucose supply and its metabolism was sufficient to
support utilization for anabolic purposes. The kinase AMPK, a
conserved cellular energy sensor,62 phosphorylates and acti-
vates TSC2 that is required to inhibit mTORC163 and, hence,
serves as a signaling nexus for energy homeostasis and nutri-
ent-sensing that inhibits protein synthesis, the most energy-
demanding anabolic process.64 Although we did not measure
cellular energy status per se, the greater p-TSC2 with increased
supply of Arg seems to confirm that activation of AMPK was
Fig. 1 Theoretical model of arginine and methionine-induced regulation of milk protein abundance via upstream mechanistic target of rapamycin
complex 1 (mTORC1) signaling and circadian clock network in bovine mammary epithelial cells. The solid lines denote the contributions observed in
the present study. Dotted lines denote relationships inconsistent with the literature.
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not the sole regulator of TSC2. There might be other kinases
specific to mammary cells that regulate this protein. For
instance, ERK-dependent phosphorylation leads to dis-
sociation of the TSC1–TSC2 complex, and markedly impairs
the ability of TSC2 to inhibit mTOR signaling.65 However, con-
trary to previous work66 the possibility exists that ERK-TSC2
signaling was not necessary for controlling p-mTOR in
response to increased supply Arg or Met. It is also noteworthy
that the addition of Met to the incArg treatment (i.e. incArg +
incMet) was needed to return CSN1S1 abundance to those of
the control or incMet, i.e. in spite of achieving the greatest
p-mTOR:tmTOR incArg led to lower CSN1S1 abundance. That
response agrees with a recent report evaluating dosage of Met
on CSN1S1 abundance in mammary cells.67
Circadian clock network
Circadian cyclic signals are generated by a series of well-
defined oscillators based on transcription-translation feedback
loops68 (TTFL, Fig. 1). At the center of this molecular machin-
ery, the CLOCK and ARNTL proteins act as transcriptional acti-
vators of CLOCK-controlled genes (CCG), which encode repres-
sors PER1 and CRY1.69,70 It is noteworthy to point out that
metabolic regulation is not a mere output function of the cir-
cadian system, but nutrient or energy levels signal back to cel-
lular clock network to reinforce circadian rhythmicity and to
adapt physiology to temporal needs.71 Some signaling mole-
cules, surrounding the core clock network, coordinate cellular
nutrient and energy metabolism in mammals,72,73 of which
AKT and AMPK were the main emphasis in the present study.
Those are at the crossroads of upstream mTORC1 signaling
and the circadian clock network.
Besides phosphorylating mTORC1, the protein AKT can
lengthen the circadian period when activated.74 In that
context, AKT might be a point through which changes in
protein synthetic metabolism impact the functioning of circa-
dian clock. This would occur via phosphorylating CLOCK
(Ser845) and ARNTL (Ser42), which subsequently influences
their nuclear/cytoplasmic shuttling.75,76 In the present study,
the lack of statistical changes in ARNTL protein abundance
due to AA treatments was inconsistent with previous work
where AKT deficiency decreased ARNTL abundance.77 Lower
p-AKT protein with increased supply of Arg could alleviate
inhibition on clock function, but the opposite response of
CLOCK protein abundance with increased Met or Arg alone or
in combination might have occurred because AKT might not
be the sole regulator of CLOCK and ARNTL in mammary cells.
The alteration of CLOCK and ARNTL abundance with
increased supply of Met and Arg might occur mainly through
other pathways. Future work should investigate the effects of
Met and Arg on other regulators of CLOCK and ARNTL.
The AMPK protein transmits energy-dependent signals to
the CLOCK partly through coordinating with SIRT1 and
NAMPT to inhibit transcriptional activity of CLOCK–ARNTL
heterodimers. A role for SIRT1 on the AMPK-mediated
responses in mammary cells78 cannot be discounted. Active
AMPK enhances SIRT1 activity by increasing cellular NAD+
levels through the upregulation of NAMPT, a rate-limiting
enzyme in NAD+ biosynthesis.79–81 There is, in fact, a mutualis-
tic interaction between activated SIRT1 and AMPK, because
the former can activate AMPK via the enzyme STK11.82,83 In
the context of the present study, the lower p-AMPK:tAMPK
with increased Arg supply might have been responsible for the
lower mRNA abundance of SIRT1 and NAMPT. Activated SIRT1
counteracts CLOCK and ARNTL function through its histone
deacetylase activity, which inhibits transcriptional activity of
CCG.84,85 This role of SIRT1 is particularly relevant because an
important function of CLOCK–ARNTL heterodimers is to acti-
vate NAMPT.86,87 Therefore, SIRT1 seems to sit at the center of
a loop coordinating the activity of AMPK and CLOCK–ARNTL
complexes. Thus, lower expression of SIRT1 in this study may
partly explain the greater abundance of CLOCK and PER1 pro-
teins with greater supply of Met or Arg.
Overall, the aforementioned link between mTORC1-
mediated protein synthesis and circadian clock feedback loops
might partly occur through the AMPK protein, which coordi-
nates intracellular energy levels. Because protein synthesis is
closely associated with intracellular energy metabolism, it is
reasonable to foresee future studies in which energy supply to
the mammary gland (e.g. glucose) can be manipulated while
holding EAA profiles constant to better study the role of AMPK
in milk protein synthesis and the circadian clock network.
Conclusions
Increasing the supply of Met and Arg to reach ratios of 2.5 : 1
Lys : Met and 1 : 1 Lys : Arg while maintaining concentrations
of other EAA constant induces alterations in mRNA abundance
of AA transporters and activity of upstream AA-sensing com-
ponents in the mTORC1 and circadian clock signaling path-
ways. The decrease of α-s1-casein protein abundance might
indicate a response of cells to a high concentration of AA.
From a practical standpoint, targeting the supply of Met and
Arg to the ideal ratio of Lys : Met and Lys : Arg (i.e. IPAA)
during established lactation should help optimize casein
protein synthesis. However, recent data underscore the poten-
tial for enhancing the supply of Met and Arg beyond those in
the IPAA as a way to enhance health and production perform-
ance, i.e. these EAA might exert a functional role beyond
serving solely as precursors for protein synthesis. Considering
that protein synthesis is one of the most energy-consuming
cellular processes and intracellular energy levels link
mTORC1-mediated protein synthesis and circadian clock feed-
back loops, future studies should control energy status and
total AA supply to explore further the underlying mechanistic
relationships in the context of milk protein synthesis.
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